National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.
Dan Xi, Ann Berger, David Shurtleff, Farah Z Zia, Sean J Belouin
Neuropharmacology June 1, 2023 DOI: 10.1016/j.neuropharm.2023.109467 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Psychedelic medicine Mental health research Psilocybin therapy Nih policy Scientific innovation |
| Citations | 11 |
| Key findings | The NIH convened a seminal speaker series on psilocybin research, with expert lectures and discussions informing a Special Issue of Neuropharmacology. |
Abstract
The U.S. National Institutes of Health (NIH) convened a seminal first ever psychedelic drug substance-focused speaker series, from April 22 to June 10, 2021, titled the "NIH Psilocybin Research Speaker Series." This speaker series provided evidence-based scientific information to the public and the scientific community. Its aims were to assess the current state of the science, the regulatory and policy landscape, as well as to identify gaps in knowledge and understanding, ultimately serving to define future research needs. The highlights of the lectures and discussion from 26 national and international distinguished experts served as the basis for this Special Issue of Neuropharmacology. This article is part of the Special Issue on "National Institutes of Health Psilocybin Research Speaker Series".
Comparable studies
Other narrative reviews on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. General population | 2019 | Integrative review | |
| The pharmacology of psilocybin | 2002 | Review | |
| Serotonin research: contributions to understanding psychoses | 2008 | Review | |
| Psychedelics, Meditation, and Self-Consciousness | 2018 | Review | |
| The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act | 2018 | Review |
Citations in the library
Cited by 8
- Psychedelics: Threshold of a Therapeutic Revolution Neuropharmacology May 27, 2023
- Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. Journal of Psychoactive Drugs 2023
- Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps Journal of Fungi January 28, 2025
- Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper European Psychiatry 2025
- Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity July 29, 2025
and 3 more in the library